NEW YORK, Aug. 2, 2017 /PRNewswire/ -- Asia-Pacific Transurethral Resection of the Prostate (TURP) Procedures Outlook to 2023 Summary GlobalData's new report, "Asia-Pacific Transurethral Resection of ...
Although transurethral resection of the prostate (TURP) is the standard treatment for benign prostatic hyperplasia (BPH), new minimally invasive methods have recently been gaining in popularity.
Medical Device Network on MSN
FDA clears Francis Medical’s water vapour ablation treatment for prostate cancer
The Vanquish device’s clinical data demonstrated an elimination of MRI visible intermediate risk disease in 91% of patients ...
TipRanks on MSN
Profound Medical to launch AI-powered BPH module
Profound Medical (PROF) announced the upcoming launch of its TULSA-AI Volume Reduction module for optimizing the treatment of patients with benign ...
At University of Utah Health, our urologists have years of experience treating men with enlarged prostate issues — also known as benign prostatic hyperplasia (BPH). When other lines of treatment ...
Discover a study on perioperative hypothermia in older urology patients, comparing remimazolam and sevoflurane for better ...
RSNA attendees can find Profound at Booth #3153, South Hall A, for demonstrations of the newly launched TULSA-AI Volume Reduction module, along with case studies and feature upgrades from the pilot ...
Bisphosphonate therapy in patients under androgen deprivation therapy for prostate cancer: A systematic review and meta-analysis. Background: Since transurethral resection of bladder tumor in one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback